Prophylactic mastectomy: why and when?

Area of Science:

• Oncology
• Genetics
• Surgical Oncology

Background:

• BRCA1 and BRCA2 gene mutations significantly increase breast cancer risk.
• Genetic testing advancements have heightened interest in risk-reducing surgeries like prophylactic mastectomy.
• Immediate breast reconstruction is often considered alongside prophylactic mastectomy.

Purpose of the Study:

• To discuss prophylactic mastectomy and immediate breast reconstruction for BRCA mutation carriers.
• To inform patients about potential risks and benefits of these procedures.
• To highlight alternative risk management strategies and the need for multidisciplinary care.

Main Methods:

• Review of current practices and literature regarding prophylactic mastectomy and reconstruction in BRCA mutation carriers.
• Discussion of potential complications and patient counseling considerations.
• Exploration of surveillance and chemoprevention as alternative strategies.

Main Results:

• Prophylactic mastectomy may reduce breast cancer risk by over 90%.
• Immediate breast reconstruction may have suboptimal cosmetic outcomes, loss of nipple sensation, and risks like capsular contracture.
• Prospective randomized trials comparing mastectomy with surveillance or chemoprevention are lacking.

Conclusions:

• Informed consent is crucial, detailing risks of prophylactic mastectomy and reconstruction.
• Surveillance and chemoprevention are viable alternatives requiring further comparative research.
• Management of BRCA mutation carriers necessitates collaboration between breast surgeons and gynecologists due to concurrent ovarian cancer risk.